☆BVF INC/IL
Quality Q
0.778
AUM ($M)
3,911
Positions
44
Turnover
0.18
Top-10 wt
66%
Herfindahl
0.062
History (qtrs)
6
Excess Return
+146.7%
AI Eval Run AI Eval
Holdings · 48 positions · portfolio value $3,911M
| Ticker | Name | Activity | Security Type | Weight | Δ Weight | Value ($M) | Shares | Δ Shares | Qtrs Held | Excess Return |
|---|---|---|---|---|---|---|---|---|---|---|
| ☆RVMD funds › | REVOLUTION MEDICINES INC | ADD | — | 14.2% | +5.3% | 555.3 | 2,965,160 | +108,378 | 5 | — |
| ☆KYMR funds › | KYMERA THERAPEUTICS INC | TRIM | — | 11.4% | -3.2% | 444.0 | 3,872,052 | -1,630,658 | 5 | — |
| ☆XOMA funds › | XOMA ROYALTY CORPORATION | ADD | — | 8.3% | +5.7% | 322.7 | 7,593,303 | +5,003,000 | 5 | — |
| ☆MLTX funds › | MOONLAKE IMMUNOTHERAPEUTICS | HOLD | — | 8.0% | -1.5% | 311.5 | 16,001,284 | +0 | 5 | — |
| ☆GHRS funds › | GH RESEARCH PLC | HOLD | — | 5.9% | +2.1% | 232.5 | 8,650,158 | +0 | 5 | — |
| ☆GPCR funds › | STRUCTURE THERAPEUTICS INC | TRIM | — | 4.6% | -0.7% | 180.7 | 3,366,823 | -92,535 | 5 | — |
| ☆NKTR funds › | NEKTAR THERAPEUTICS | TRIM | — | 4.3% | -1.6% | 166.9 | 2,391,075 | -168,520 | 4 | +146.7% |
| ☆MIRM funds › | MIRUM PHARMACEUTICALS INC | TRIM | — | 3.2% | -1.5% | 123.6 | 1,056,027 | -528,700 | 5 | — |
| ☆XNCR funds › | XENCOR INC | HOLD | — | 2.9% | +0.2% | 114.9 | 7,133,720 | +0 | 5 | — |
| ☆ALKS funds › | ALKERMES PLC | ADD | — | 2.9% | +0.6% | 112.9 | 2,154,704 | +154,704 | 2 | +95.5% |
| ☆GLUE funds › | MONTE ROSA THERAPEUTICS INC | HOLD | — | 2.8% | +0.4% | 108.0 | 4,460,886 | +0 | 5 | — |
| ☆CGEM funds › | CULLINAN THERAPEUTICS INC | HOLD | — | 2.7% | +0.1% | 104.7 | 5,750,683 | +0 | 5 | — |
| ☆PVLA funds › | PALVELLA THERAPEUTICS INC NE | TRIM | — | 2.6% | -1.2% | 102.8 | 672,789 | -288,200 | 5 | — |
| ☆ZYME funds › | ZYMEWORKS INC | TRIM | — | 2.4% | -0.5% | 95.4 | 3,649,142 | -85,000 | 5 | — |
| ☆KURA funds › | KURA ONCOLOGY INC | HOLD | — | 2.4% | +0.2% | 92.7 | 8,445,769 | +0 | 5 | — |
| ☆IRON funds › | DISC MEDICINE INC | TRIM | — | 2.2% | -0.4% | 84.4 | 1,153,612 | -118,700 | 3 | -40.5% |
| ☆STOK funds › | STOKE THERAPEUTICS INC | HOLD | — | 2.1% | -0.5% | 83.4 | 2,547,557 | +0 | 4 | +50.0% |
| ☆OLMA funds › | OLEMA PHARMACEUTICALS INC | HOLD | — | 1.7% | -0.8% | 66.3 | 5,295,893 | +0 | 5 | — |
| ☆ANNX funds › | ANNEXON INC | HOLD | — | 1.3% | -0.3% | 49.7 | 8,698,173 | +0 | 5 | — |
| ☆CBIO funds › | CRESCENT BIOPHARMA INC. | HOLD | — | 1.3% | -0.3% | 49.5 | 2,748,763 | +0 | 5 | -51.5% |
| ☆ACIU funds › | AC IMMUNE SA | HOLD | — | 1.2% | -0.5% | 47.2 | 19,822,436 | +0 | 5 | — |
| ☆TYRA funds › | TYRA BIOSCIENCES INC | TRIM | — | 1.2% | -1.2% | 47.1 | 1,476,196 | -500,000 | 5 | — |
| ☆STRO funds › | SUTRO BIOPHARMA INC | HOLD | — | 1.1% | +0.1% | 41.6 | 1,251,788 | +0 | 2 | +21.6% |
| ☆IMCR funds › | IMMUNOCORE HLDGS PLC | HOLD | — | 1.1% | -0.2% | 41.1 | 1,294,463 | +0 | 5 | -15.3% |
| ☆AVTX funds › | AVALO THERAPEUTICS INC | ADD | — | 1.0% | +0.2% | 38.4 | 2,075,545 | +442,700 | 5 | — |
| ☆FDMT funds › | 4D MOLECULAR THERAPEUTICS IN | HOLD | — | 1.0% | +0.1% | 38.3 | 2,879,289 | +0 | 5 | — |
| ☆QTTB funds › | Q32 BIO INC | NEW | — | 0.8% | +0.8% | 29.9 | 2,350,000 | +2,350,000 | 1 | +5451.8% |
| ☆AVR funds › | ANTERIS TECHNOLOGIES GLOBAL | HOLD | — | 0.8% | +0.2% | 29.6 | 3,000,000 | +0 | 2 | +154.7% |
| ☆FHTX funds › | FOGHORN THERAPEUTICS INC | HOLD | — | 0.7% | -0.2% | 28.5 | 5,842,000 | +0 | 5 | — |
| ☆ABSI funds › | ABSCI CORPORATION | NEW | Common Stock | 0.7% | +0.7% | 27.4 | 2,361,674 | +2,361,674 | 1 | +1179.4% |
| ☆ELDN funds › | ELEDON PHARMACEUTICALS INC | HOLD | — | 0.6% | +0.0% | 24.8 | 6,293,282 | +0 | 5 | — |
| ☆IVVD funds › | INVIVYD INC | ADD | — | 0.6% | -0.2% | 24.6 | 28,165,000 | +8,640,000 | 3 | -108.9% |
| ☆SGMT funds › | SAGIMET BIOSCIENCES INC | NEW | — | 0.5% | +0.5% | 19.3 | 2,500,000 | +2,500,000 | 1 | +550.6% |
| ☆OKUR funds › | ONKURE THERAPEUTICS INC | ADD | — | 0.4% | +0.1% | 14.8 | 3,235,778 | +1,256,806 | 2 | +152.2% |
| ☆IMUX funds › | IMMUNIC INC | NEW | — | 0.3% | +0.3% | 11.8 | 765,295 | +765,295 | 1 | +253.4% |
| ☆XFOR funds › | X4 PHARMACEUTICALS INC | HOLD | — | 0.3% | -0.0% | 10.4 | 2,233,742 | +0 | 4 | +26.2% |
| ☆IMA funds › | IMAGENEBIO INC | HOLD | — | 0.2% | -0.0% | 6.5 | 1,110,002 | +0 | 4 | -81.1% |
| ☆TCRX funds › | TSCAN THERAPEUTICS INC | HOLD | — | 0.1% | -0.0% | 5.5 | 5,564,290 | +0 | 5 | — |
| ☆RACC funds › | RESEARCH ALLIANCE CORP III | NEW | — | 0.1% | +0.1% | 5.3 | 500,000 | +500,000 | 1 | +5866.4% |
| ☆MOLN funds › | MOLECULAR PARTNERS AG | HOLD | — | 0.1% | -0.0% | 5.1 | 1,353,968 | +0 | 5 | — |
| ☆TENX funds › | TENAX THERAPEUTICS INC | HOLD | — | 0.1% | -0.0% | 4.9 | 339,549 | +0 | 5 | — |
| ☆ENTX funds › | ENTERA BIO LTD | NEW | — | 0.1% | +0.1% | 4.3 | 2,425,000 | +2,425,000 | 1 | +3341.8% |
| ☆IVA funds › | INVENTIVA SA | HOLD | — | 0.1% | -0.1% | 2.6 | 686,040 | +0 | 5 | — |
| ☆ENGNW funds › | ENGENE THERAPEUTICS | NEW | — | 0.0% | +0.0% | 0.3 | 945,402 | +945,402 | 1 | — |
| ☆CMPX funds › | COMPASS THERAPEUTICS INC | EXIT | — | 0.0% | -1.3% | 0.0 | 0 | -7,764,842 | 0 | -68.7% |
| ☆SEPN funds › | SEPTERNA INC | EXIT | — | 0.0% | -1.0% | 0.0 | 0 | -1,353,249 | 0 | — |
| ☆CUSIP:4525EP101 funds › | IMMUNIC INC | EXIT | — | 0.0% | -0.3% | 0.0 | 0 | -7,652,972 | 0 | — |
| ☆CUSIP:29286M113 funds › | ENGENE HOLDINGS INC | EXIT | — | 0.0% | -0.1% | 0.0 | 0 | -945,402 | 0 | — |
Point-in-time history
| Period | AUM ($M) | Positions | Turnover | Top-10 wt | Herfindahl | Quality Q | Skill | Universe |
|---|---|---|---|---|---|---|---|---|
| 2026Q2 | 3,911 | 44 | 0.18 | 66% | 0.062 | 0.775 | — | in |
| 2026Q1 | 3,139 | 41 | 0.14 | 62% | 0.058 | 0.797 | — | in |
| 2025Q4 | 2,971 | 41 | 0.24 | 63% | 0.058 | 0.563 | — | in |
| 2025Q3 | 2,467 | 46 | 0.37 | 59% | 0.049 | 0.252 | — | in |
| 2025Q2 | 2,799 | 44 | 0.10 | 77% | 0.139 | 0.899 | — | entered |
| 2025Q1 | 2,454 | 51 | 0.00 | 73% | 0.125 | 0.000 | — | out |
Long US-equity 13F disclosures only · up to 45-day reporting lag · sells = reduce/avoid, not short.
JSON: /api/signals ·
/api/funds ·
/api/status